Viking Therapeutics advances obesity pill

Market update for Thursday February 12, 2026

Check out the Public app for incredible investing tools and to support the show (LINK)

Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.

In today’s episode:

• AI disruption concerns continue to pressure financial and software stocks
• McDonald’s U.S. same-store sales jump 6.8%
• Kraft Heinz pauses its planned breakup and commits $600M to revive growth
• Viking Therapeutics rallies as it advances its oral obesity pill to Phase 3 trials
• Cisco beats earnings but falls on margin pressure and cautious AI guidance
• Fun Fact: Americans are spending more of the workday sitting